During United Rheumatology’s national meeting in Orlando, Dr. Alan L. Epstein, a member of UR’s Medical Policy Committee, presented on Biosimilars – A Clinical Update. Dr. Epstein’s presentation serves as a strong reference point for where biosimilars are currently positioned for treating rheumatologic diseases. Given recent and forthcoming product releases in our space, members are encouraged to review Dr. Epstein’s presentation.